![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Approves Roche’s EGFR Mutation Test
FDA Approves Roche’s EGFR Mutation Test
![roche.gif](https://www.fdanews.com/ext/resources/test/Device_Images/roche.gif?t=1600727553&width=430)
The FDA has greenlighted Roche’s liquid biopsy Cobas EGFR Mutation Test v2 for the detection of the epidermal growth factor receptor gene linked to non-small cell lung cancer.
The companion diagnostic test is the first FDA-approved one designed to pinpoint the EGFR gene in DNA from plasma or tumor tissue. The test is a companion diagnostic for cancer drug Tarceva. — Anisa Jibrell
Upcoming Events
-
11Jul
-
18Jul
-
21Oct